Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Advanced Prostate Cancer - The evolving landscape and targeted therapies

Prof Nicholas Mottet, Prof Amit Bahl, Prof Piet Ost and Dr Inge Van Oort

Advanced Prostate Cancer - The evolving landscape and targeted therapies ( Prof Nicholas Mottet, Prof Amit Bahl, Prof Piet Ost and Dr Inge Van Oort )

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )

Treating CLL with obinutuzumab

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany

Treating CLL with obinutuzumab ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )

First in-human trial of AMV564 for AML

Prof Peter Westervelt - Washington University School of Medicine, St Louis, USA

First in-human trial of AMV564 for AML ( Prof Peter Westervelt - Washington University School of Medicine, St Louis, USA )

SETBP1 induces transcription of developmental genes

Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy

SETBP1 induces transcription of developmental genes ( Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy )

Combination therapy for CLL in the CAPTIVATE trial

Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

Combination therapy for CLL in the CAPTIVATE trial ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )

Efficacy of novel agents in r/r T pro-lymphocytic leukaemia

Prof Philipp Staber - Medical University of Vienna, Vienna, Austria

Efficacy of novel agents in r/r T pro-lymphocytic leukaemia ( Prof Philipp Staber - Medical University of Vienna, Vienna, Austria )

Isatuximab in combination to treat relapsed/refractory MM

Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma...

$Isatuximab in combination to treat relapsed/refractory MM ( Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation )$

ICLL07 FILO study: Minimal residual disease still detectable after first line...

Prof Pierre Feugier - University of Lorraine, Nancy, France

ICLL07 FILO study: Minimal residual disease still detectable after first line combination therapy ( Prof Pierre Feugier - University of Lorraine, Nancy, France )

The mutational landscape of AML

Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany

The mutational landscape of AML ( Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany )

More from ecancer